Benzinga - Fri, 09 Apr 2021 05:04:24 -0400
Benzinga - Thu, 08 Apr 2021 13:08:40 -0400
Benzinga - Thu, 08 Apr 2021 11:22:48 -0400
Benzinga - Thu, 08 Apr 2021 10:17:06 -0400
Benzinga - Thu, 08 Apr 2021 08:11:19 -0400
Benzinga - Thu, 08 Apr 2021 08:06:23 -0400
Benzinga - Thu, 08 Apr 2021 06:02:17 -0400
Benzinga - Wed, 31 Mar 2021 07:41:11 -0400
Benzinga - Wed, 17 Mar 2021 07:49:42 -0400
Benzinga - Wed, 17 Mar 2021 07:43:07 -0400
Benzinga - Wed, 17 Mar 2021 07:42:05 -0400
Benzinga - Tue, 16 Mar 2021 16:22:52 -0400
Benzinga - Fri, 26 Feb 2021 08:04:29 -0400
Benzinga - Wed, 13 Jan 2021 08:02:26 -0400
Benzinga - Tue, 05 Jan 2021 09:38:54 -0400
load more
Sector: Health Care.Industry: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-14
REV
Q4 2020Est.ActualSurprise
EPS-0.730
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
APREAprea Therapeutics-11.07%93.6M

Aprea Therapeutics Company Questions & Answers

Q

How do I buy Aprea Therapeutics (APRE) stock?

A

You can purchase shares of Aprea Therapeutics (NASDAQ: APRE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aprea Therapeutics's (APRE) main competitors?

A

Other companies in Aprea Therapeutics’s space includes: Lumos Pharma (NASDAQ:LUMO), CollPlant Biotechnologies (NASDAQ:CLGN) and BioLine Rx (NASDAQ:BLRX).

Q

What is the target price for Aprea Therapeutics?

A

The latest price target for Aprea Therapeutics (NASDAQ: APRE) was reported by RBC Capital on 2021-03-17. The analyst firm set a price target for 8.00 expecting APRE to rise to within 12 months (a possible 81.00% upside). 7 analyst firms have reported ratings in the last year.

Q

How much is Aprea Therapeutics (APRE) stock ?

A

The stock price for Aprea Therapeutics (NASDAQ: APRE) is $4.42 last updated Mon Apr 12 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Aprea Therapeutics (APRE) dividend?

A

There are no upcoming dividends for Aprea Therapeutics.

Q

When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?

A
Aprea Therapeutics’s Q1 earnings are confirmed from now on May 14, 2021.
Q

When is the upcoming split for APRE?

A

There is no upcoming split for Aprea Therapeutics.